Neogenomics (NEO) Acquisitions (2014 - 2025)
Neogenomics' (NEO) quarterly Acquisitions came in at $463000.0 in Q3 2025, down 99.89% on a QoQ basis from $419.4 million in Q2 2021.
Neogenomics (NEO) Acquisitions (2014 - 2025) Analysis & Trends
Neogenomics (NEO) has 4 years of Acquisitions data on file, last reported at $463000.0 in Q3 2025.
- Quarterly Acquisitions changed N/A year-over-year to $463000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $463000.0 (changed N/A YoY) and the FY2025 annual result came in at $6.5 million, changed N/A from the prior year.
- Acquisitions fell to $463000.0 in Q3 2025, from $419.4 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $419.4 million in Q2 2021 to a low of $463000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 163.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 2.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 225.70 Mn |
| 10 | Neogenomics | 2.42 Bn | 2.28 Bn | 91.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 463,000.00 |
| Jun 30, 2021 | 419.40 Mn |
| Mar 31, 2020 | 37.00 Mn |
| Dec 31, 2014 | 1,000.00 |